Press Releases
MISSISSAUGA, ON, July 23, 2018 /CNW/ - Cipher Pharmaceuticals Inc. (TSX:CPH) ("Cipher" or "the Company") today announced the details of its Q2 2018 financial results conference call on Friday, August 10, 2018. The call will be hosted by Robert Tessarolo, President and Chief Executive Officer, and Stephen Lemieux, Chief Financial Officer. Cipher will issue its financial results on the morning of August 10, 2018.
CONFERENCE CALL DETAILS
|
DATE: |
Friday, August 10, 2018 |
|
TIME: |
8:30 a.m. EDT |
|
DIAL IN NUMBER: |
(416) 764-8609 or (888) 390-0605 |
|
CONFERENCE ID: |
25005708 |
|
REPLAY: |
(888) 390-0541 (playback code 005708) |
|
Available until midnight (EST) August 17, 2018 | |
|
WEBCAST: |
The audio webcast can be accessed at http://cipher.investorroom.com/ under Investor Relations or at https://bit.ly/2mD9mUa |
About Cipher Pharmaceuticals Inc.
Cipher (TSX:CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products either directly in Canada or indirectly through partners in Canada, the U.S., and South America. Cipher is focused on a three-pronged growth strategy – including acquisitions, in-licensing, and selective investments in drug development – to assemble a broad portfolio of prescription products that serve unmet medical needs. For more information, visit www.cipherpharma.com.
SOURCE Cipher Pharmaceuticals Inc.
